CV Sciences investor holds 10.25% stake, 26.6M shares
A ten percent owner of CV Sciences, Inc. reports over 26.6 million beneficially owned shares, including direct and trust holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CV Sciences, Inc. (CVSI) disclosed in a Form 3 that Charlie E. Cheever III is a ten percent owner of the company. As of July 9, 2026, the filing states that securities beneficially owned by Cheever and an associated trust total 26,648,711 shares, representing 10.25% of CV Sciences. This includes 20,026,195 shares of common stock held directly and 881,700 shares held indirectly through a trust for which Cheever serves as trustee with voting and dispositive power.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock, $0.0001 par value per share | -- | -- | -- |
| holding | Common Stock, $0.0001 par value per share F1 | -- | -- | -- |
Footnotes (1)
- F1. Represents 881,700 shares of Common Stock held in Trust, for which the Reporting Person serves as trustee. The Reporting Person has voting and dispositive power over the shares held by the Trust.
Key Figures
Key Terms
beneficially owned financial
ten percent owner regulatory
voting and dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 for CVSI disclose about Charlie E. Cheever III’s ownership?
What percentage of CV Sciences, Inc. does Charlie E. Cheever III beneficially own?
AI-generated analysis. How Rhea-AI works. Not financial advice.